HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoe Goto Selected Research

VAP-cyclo protocol

6/2017CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
1/2014Serum soluble tumor necrosis factor receptor 1 level is associated with the outcome of diffuse large B-cell lymphoma patients treated with the CHOP or R-CHOP regimen.
10/2013Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
5/2012Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoe Goto Research Topics

Disease

15Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2017 - 06/2005
8Neoplasms (Cancer)
11/2017 - 10/2002
8Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2015 - 02/2005
6Lymphoma (Lymphomas)
06/2019 - 06/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2012
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2017 - 01/2009
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2015 - 05/2014
2Multiple Myeloma
07/2014 - 01/2010
2Neutropenia
10/2011 - 12/2005
2Fever (Fevers)
11/2010 - 12/2005
2Hematologic Neoplasms (Hematological Malignancy)
11/2010 - 06/2008
2Febrile Neutropenia
11/2010 - 06/2008
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2017
1Type 2 Diabetes Mellitus (MODY)
11/2017
1Carcinogenesis
10/2017
1Inflammation (Inflammations)
10/2017
1Cardiotoxicity
06/2017
1Ulcer
01/2016
1Duodenal Ulcer (Curling's Ulcer)
01/2016
1Melena
01/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Abdominal Pain (Pain, Abdominal)
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Fistula
01/2016
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2015
1Seminoma
01/2015
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2014
1Genetic Translocation (Chromosomal Translocation)
09/2014
1Cytokine Release Syndrome
07/2014
1Melanoma (Melanoma, Malignant)
02/2014
1Immunoglobulin G4-Related Disease
04/2013
1Aspiration Pneumonia
03/2013
1Anemia
10/2011
1Mycoses (Diseases, Fungus)
11/2010
1Skin Ulcer
01/2010
1Monoclonal Gammopathy of Undetermined Significance
01/2010
1Cryoglobulinemia
01/2010
1Peptic Esophagitis (Reflux Esophagitis)
12/2006

Drug/Important Bio-Agent (IBA)

12Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 12/2005
11Prednisolone (Predate)FDA LinkGeneric
12/2017 - 12/2005
11Vincristine (Oncovin)FDA LinkGeneric
12/2017 - 12/2005
11Rituximab (Mabthera)FDA Link
09/2017 - 10/2009
10Doxorubicin (Adriamycin)FDA LinkGeneric
12/2017 - 01/2010
5pirarubicinIBA
12/2017 - 12/2005
5KynurenineIBA
12/2017 - 04/2010
3Immunoglobulin G (IgG)IBA
01/2022 - 01/2010
3Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2015 - 04/2011
3Interleukin-2 Receptors (IL 2 Receptor)IBA
05/2012 - 02/2005
2Anti-Bacterial Agents (Antibiotics)IBA
12/2015 - 03/2013
2Type II Tumor Necrosis Factor ReceptorsIBA
10/2013 - 09/2006
2Monoclonal AntibodiesIBA
04/2011 - 06/2005
1R-CHOP protocolIBA
06/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2017
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2017
1Glycoside Hydrolase InhibitorsIBA
11/2017
1ProgranulinsIBA
10/2017
1Glycoproteins (Glycoprotein)IBA
10/2017
1IfosfamideFDA LinkGeneric
09/2017
1Etoposide (VP 16)FDA LinkGeneric
09/2017
1Methotrexate (Mexate)FDA LinkGeneric
09/2017
1Carboplatin (JM8)FDA LinkGeneric
09/2017
1MethylprednisoloneFDA LinkGeneric
09/2017
12- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA
06/2017
1AnthracyclinesIBA
06/2017
1Pharmaceutical PreparationsIBA
01/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1Bevacizumab (Avastin)FDA Link
01/2016
1Interleukin-1 (Interleukin 1)IBA
12/2015
1Interleukin-8 (Interleukin 8)IBA
12/2015
1InterleukinsIBA
12/2015
1Interleukin-4 (Interleukin 4)IBA
12/2015
1CytokinesIBA
12/2015
1Messenger RNA (mRNA)IBA
09/2015
1Tryptophan (L-Tryptophan)FDA Link
09/2015
1Keratins (Keratin)IBA
04/2015
1CollagenIBA
04/2015
1ChromatinIBA
04/2015
1Granzymes (Granzyme)IBA
01/2015
1Cyclin D1IBA
09/2014
1Lenalidomide (CC 5013)FDA Link
07/2014
1ParaffinIBA
05/2014
1Formaldehyde (Formol)FDA Link
05/2014
1Ligases (Synthetase)IBA
02/2014
1UbiquitinIBA
02/2014
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2014
1CopperIBA
10/2011
1Interleukin-18 (Interleukin 18)IBA
09/2011
1Prednisone (Sone)FDA LinkGeneric
04/2011
1Micafungin (FK463)FDA Link
11/2010
1CryoglobulinsIBA
01/2010
1Melphalan (Alkeran)FDA LinkGeneric
01/2010
1Immunoglobulin A (IgA)IBA
01/2010
1biapenem (L 627)IBA
06/2008
1Serum AlbuminIBA
12/2006
1Proteins (Proteins, Gene)FDA Link
06/2006

Therapy/Procedure

8Therapeutics
09/2017 - 01/2010
4Drug Therapy (Chemotherapy)
06/2019 - 12/2005
4VAP-cyclo protocol
06/2017 - 05/2012
2Aftercare (After-Treatment)
03/2013 - 10/2009